Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Erythromycin and other macrolide antibiotics have been examined for their effects on ribosome assembly in growing Escherichia coli cells. Formation of the 50S ribosomal subunit was specifically inhibited by erythromycin and azithromycin. Other related compounds tested, including oleandomycin, clarithromycin, spiramycin, and virginiamycin M1, did not influence assembly. Erythromycin did not promote the breakdown of ribosomes formed in the absence of the drug. Two erythromycin-resistant mutants with alterations in ribosomal proteins L4 and L22 were also examined for an effect on assembly. Subunit assembly was affected in the mutant containing the L22 alteration only at erythromycin concentrations fourfold greater than those needed to stop assembly in wild-type cells. Ribosomal subunit assembly was only marginally affected at the highest drug concentration tested in the cells that contained the altered L4 protein. These novel results indicate that erythromycin has two effects on translation, preventing elongation of the polypeptide chain and also inhibiting the formation of the large ribosomal subunit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron is also strongly implicated in non-alcoholic steatohepatitis, considered an early marker of insulin resistance [622-624].”
Citations
Cites
The Molecular Basis of Antibiotic Action
Gale, E. F. (1981) · Medical Entomology and Zoology · Cited by 1,217
The ribosome: Structure, function and evolution
Edward, B., & Baden, H. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90126-g · Cited by 508
Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., & Mason, R. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1939 · Cited by 464 · cited 1×
“However, azithromycin, a novel 15-membered erythromycin derivative [34, 47], was as effective as erythromycin in inhibiting subunit assembly (Fig.”
BackgroundMoazed, D., & Noller, H. F. (1987) · Biochimie · doi:10.1016/0300-9084(87)90215-x · Cited by 335 · cited 2×
“Sequence analysis and protection studies have also indicated that changes in domain II of the secondary structure of 23S RNA can also give rise to erythromycin resistance [16, 23].”
BackgroundInhibitors of protein biosynthesis
(2006) · Biochemistry and Molecular Biology of Antimicrobial Drug Action · doi:10.1007/0-387-27566-5_5 · Cited by 318
Skinner, R., Cundliffe, E., & Schmidt, F. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44232-3 · Cited by 263 · cited 1×
“Methylation of a single adenine residue in domain V can confer drug resistance in several different organisms [37].”
BackgroundInhibitors of Protein Biosynthesis
Vázquez, D. (1979) · Molecular Biology Biochemistry and Biophysics · doi:10.1007/978-3-642-81309-2 · Cited by 238 · cited 1×
“Lincomycin, the 16-membered macrolide spiramycin, and the streptogramin A compound viriginiamycin M1 are also antibiotics that affect translation at a step or site related to that inhibited by the macrolides [44].”
BackgroundGuthrie, C., Nashimoto, H., & Nomura, M. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.63.2.384 · Cited by 184
Vaara, M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.354 · Cited by 170 · cited 1×
“It is also important to note that in a number of different organisms, the efficacy of erythromycin and azithromycin in vivo is much greater than that of oleandomycin or spiramycin, consistent with a potential additional effect of the former compounds [25, 42, 47].”
BackgroundWittmann, H. G., Stöffler, G., Apirion, D., Rosen, L., Tanaka, K., Tamaki, M., Takata, R., Dekio, S., Otaka, E., & Osawa, S. (1973) · Molecular and General Genetics MGG · doi:10.1007/bf00333665 · Cited by 169 · cited 4×
“Strain N281 has a mutation affecting protein L22, and strain N282 is altered in protein IA [49].”
BackgroundInfluential
Research works printed but not linked: 7
- Apirion D (1967) Three genes that affect Escherichia coli ribosomes. J Mol Biol 30:255?275
- Cundliffe E (1980) Antibiotics and prokaryotic ribosomes: action, interaction and resistance. In: Chambliss G, Craven GR, Davies J, Davis K, Kahan L, Nomura M (eds). Ribosomes, structure, function and genetics. Baltimore: University Park Press, pp 555?581
- Cundliffe E (1990) Recognition sites for antibiotics within rRNA. In: Hill WE, Dahlberg A, Garrett RA, Moore PB, Schlessinger D, Warner JR (eds), The ribosome: structure, function and evolution. Washington, DC: Am Soc Microbiol, pp 479?490
- Nakagawa A, Omura S (1984) Structure and stereochemistry of macrolides. In: Omura S (ed), Macrolide antibiotics. Orlando, FL: Academic Press, pp 37?84
- Nakayama I (1984) Macrolides in clinical practice. In: Omura S (ed), Macrolide antibiotics Orlando, FL: Academic Press, pp 261?300
- Omura S (1984) Macrolide antibioties. Orlando, FL: Academic Press
- Omura S, Tanaka H (1984) Production and antimicrobial activity of macrolides. In: Omura S (ed), Macrolide antibiotics. Orlando, FL: Academic Press, pp 3?35
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“Iron is also strongly implicated in non-alcoholic steatohepatitis, considered an early marker of insulin resistance [532-534].”
BackgroundThe macrolide antibiotic renaissance
Dinos, G. P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13936 · Cited by 471
“Champney and co-workers have shown that macrolides inhibit ribosome assembly (Chittum and Champney, 1995; Champney and Miller, 2002; Champney and Pelt, 2002), but this results from a secondary effect due to the inhibition of synthesis of ribosomal proteins (Siibak et al., 2009).”
BackgroundTait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance
Gaynor, M., & Mankin, A. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452159 · Cited by 235
“Interference with ribosome assembly may contribute further to the overall inhibitory activity of macrolides [38,39].”
BackgroundMacrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin
Gomes, C., Martínez‐Puchol, S., Palma, N., Horna, G., Ruiz‐Roldán, L., Pons, M. J., & Ruiz, J. (2016) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1136261 · Cited by 184
Gregory, S. T., & Dahĺberg, A. E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2839 · Cited by 154
Garza-Ramos, G., Xiong, L., Zhong, P., & Mankin, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6898-6907.2001 · Cited by 136
Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli
Chittum, H. S., & Champney, W. S. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.20.6192-6198.1994 · Cited by 134
Self-citationZaman, S., Fitzpatrick, M., Lindahl, L., & Zengel, J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05975.x · Cited by 102
“Because erythromycin has been shown to affect 50S subunit assembly (Chittum and Champney, 1995; Usary and Champney, 2001; Champney, 2006), we wanted to determine whether the aberrant profile was due to the presence of the antibiotic or the mutations in L4 and L22.”
BackgroundHawkyard, C. V., & Koerner, R. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl537 · Cited by 111
Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells
Usary, J., & Champney, W. S. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02438.x · Cited by 86
Self-citationChampney, W. S., & Burdine, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2141 · Cited by 89
Self-citationChampney, W. S., & Burdine, R. (1998) · Current Microbiology · doi:10.1007/s002849900290 · Cited by 69
Self-citationUnge, J., AÅberg, Al-Kharadaghi, S., Никулин, А. Д., Nikonov, S. Y., Davydova, N. L., Nevskaya, N. A., Garber, M., & Liljas, A. (1998) · Structure · doi:10.1016/s0969-2126(98)00155-5 · Cited by 58
Diner, E. J., & Hayes, C. S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.064 · Cited by 62
Champney, W. S., Tober, C. L., & Burdine, R. (1998) · Current Microbiology · doi:10.1007/s002849900402 · Cited by 53
Self-citationComparative genomic assessment of novel broad‐spectrum targets for antibacterial drugs
White, T. A., & Kell, D. B. (2004) · Comparative and Functional Genomics · doi:10.1002/cfg.411 · Cited by 52
Champney, W. S., & Burdine, R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1301 · Cited by 51
Self-citationThe CRISPR-cas System Promotes Antimicrobial Resistance in Campylobacter Jejuni
Shabbir, M. A. B., Wu, Q., Shabbir, M. Z., Sajid, A., Ahmed, S., Sattar, A., Tang, Y., Li, J., Maan, M. K., Hao, H., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0234 · Cited by 48
L22 Ribosomal Protein and Effect of Its Mutation on Ribosome Resistance to Erythromycin
Davydova, N., Streltsov, V. A., Wilce, M. C. J., Liljas, A., & Garber, M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00772-6 · Cited by 52
Srinivasan, B., Tonddast‐Navaei, S., Roy, A., Zhou, H., & Skolnick, J. (2018) · Medicinal Research Reviews · doi:10.1002/med.21538 · Cited by 49
“tetracyclins),(15) or the 50S ribosomal subunit and obstruct the exit tunnel (macrolide antibiotics, eg, erythromycin).(16)”
BackgroundWorbs, M., Huber, R., & Wahl, M. C. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.807 · Cited by 48
Modulating co-translational protein folding by rational design and ribosome engineering
Ahn, M., Włodarski, T., Mitropoulou, A., Chan, S. H. S., Sidhu, H., Plessa, E., Becker, T. A., Budisa, N., Waudby, C. A., Beckmann, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31906-z · Cited by 45
“FLN5 with linker lengths ( L ) of 31, 34 and 37 (Supplementary Fig.”
BackgroundBioassay-Guided Evolution of Glycosylated Macrolide Antibiotics in Escherichia coli
Lee, H., & Khosla, C. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050045 · Cited by 45
“Because 6-deoxyerythromycins are less active than the corresponding erythromycins [30,31], the biosynthetic efficiency of the two-sugar pathway was judged to be .”
Yagnik, D., Ward, M., & Shah, A. J. (2021) · Scientific Reports · doi:10.1038/s41598-020-78407-x · Cited by 42
Ketolide Resistance Conferred by Short Peptides
Tripathi, S., Kloss, P., & Mankin, A. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20073 · Cited by 48
Quantitative Proteomic Analysis of Ribosome Assembly and Turnover In Vivo
Sykes, M. T., Shajani, Z., Sperling, E., Beck, A. H., & Williamson, J. R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.005 · Cited by 40
“Previous work using different antibiotics has established a precedent for the inhibition of 50S assembly by antibiotics.(26,27) The composition of the precursor particles for both the 30S and 50S subunits was analyzed throughout the continuum, and a heterogeneous population was observed at each point in the continuum,…”
BackgroundTime-Resolved Binding of Azithromycin to Escherichia coli Ribosomes
Petropoulos, A. D., Kouvela, E. C., Starosta, A. L., Wilson, D. N., Dinos, G. P., & Kalpaxis, D. L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.042 · Cited by 43
The streptogramin antibiotics: update on their mechanism of action
Beyer, D., & Pepper, K. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.4.591 · Cited by 42
Effect of antibiotics on large ribosomal subunit assembly reveals possible function of 5 S rRNA
Khaitovich, P., & Mankin, A. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3030 · Cited by 40
Yassin, A., & Mankin, A. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703106200 · Cited by 39
Antiangiogenic Effect of Erythromycin: An In Vitro Model ofBartonella quintanaInfection
Meghari, S., Rolain, J., Grau, G. E., Platt, E., Barrassi, L., Mège, J., & Raoult, D. (2006) · The Journal of Infectious Diseases · doi:10.1086/499276 · Cited by 39
Siibak, T., Peil, L., Dönhöfer, A., Brauer, A., Remm, M., Wilson, D. N., Tenson, T., & Rèmme, J. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07555.x · Cited by 47
“In the 1990s it was recognized that erythromycin also causes accumulation of defective ribosomal particles (Chittum and Champney, 1995).”
BackgroundLawrence, M. G., Shamsuzzaman, M., Kondopaka, M., Pascual, C., Zengel, J. M., & Lindahl, L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw493 · Cited by 36
“Previous studies showed that insertion or missense mutations in the uL4 loop strongly reduce ribosome affinity for macrolide antibiotics, while mutations in the uL22 loop have little effect (34,43).”
BackgroundLozano-Huntelman, N. A., Singh, N. P., Valencia, A., Mira, P., Sakayan, M., Boucher, I. W., Tang, S. S., Brennan, K., Gianvecchio, C., Fitz‐Gibbon, S. T., et al. (2019) · Evolutionary Applications · doi:10.1111/eva.12903 · Cited by 33
“…that are associated with resistance to their respective antibiotic (Besier, Ludwig, Ludwig, Brade, & Wichelhaus, 2003; Bodley, Zieve, Zieve, Lin, & Zieve, 1969; Chittum & Champney, 1995; Davydova, Streltsov, Streltsov, Wilce, Liljas, & Garber, 2002; Sreedharan, Peterson, Peterson, & Fisher, 1991).”
Vimberg, V., Xiong, L., Bailey, M., Tenson, T., & Mankin, A. S. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04290.x · Cited by 38
Antibiotics targeting bacterial ribosomal subunit biogenesis
Champney, W. S. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz544 · Cited by 33
Self-citationMacrolides, Clindamycin, and Ketolides
Sivapalasingam, S., & Steigbigel, N. H. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00029-1 · Cited by 35
Innovative approaches to novel antibacterial drug discovery
Trias, J., & Gordon, E. M. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80131-0 · Cited by 35
Awan, A., Brennan, R., Regan, A. C., & Barber, J. (2000) · Journal of the Chemical Society Perkin Transactions 2 · doi:10.1039/b003000g · Cited by 31
Champney, W. S., & Tober, C. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1413-1417.2000 · Cited by 30
Self-citationStructure?Activity Relationships for Three Macrolide Antibiotics in Haemophilus influenzae
Mabe, S., Eller, J., & Champney, W. S. (2004) · Current Microbiology · doi:10.1007/s00284-004-4312-9 · Cited by 29
Self-citationToxic effects of erythromycin on photosystem I and II in Microcystis aeruginosa
Deng, C. N., Zhang, D. Y., & Pan, X. (2014) · Photosynthetica · doi:10.1007/s11099-014-0063-4 · Cited by 27
“Erythromycin may penetrate the cell walls of bacteria and reversibly binds to the 50S subunit of the ribosome, inhibiting RNA-dependent protein synthesis of bacteria (Pestka 1976, Chittum and Champney 1995).”
BackgroundChampney, W. S., & Burdine, R. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.169 · Cited by 24
Self-citationCarey, A. M., Capik, S. F., Giebel, S., Nickodem, C. A., Piñeiro, J. M., Scott, H. M., Vinasco, J., & Norman, K. N. (2022) · Microorganisms · doi:10.3390/microorganisms10020411 · Cited by 27
“coli to erythromycin through multiple mechanisms [16,56,57].”
Thompson, C. R., Champion, M. M., & Champion, P. A. D. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00373 · Cited by 21
Silvers, J. A., & Champney, W. S. (2005) · Archives of Microbiology · doi:10.1007/s00203-005-0017-0 · Cited by 28
“2002) and it is an inhibitor of 50S subunit assembly in this organism (Chittum and Champney 1995).”
MethodInfluentialSelf-citationEvaluation of macrolides for possible use against multidrug-resistantMycobacterium tuberculosis
van der Paardt, A.-F., Wilffert, B., Akkerman, O. W., de Lange, W. C. M., van Soolingen, D., Sinha, B. N. M., van der Werf, T. S., Kosterink, J. G. W., & Alffenaar, J. C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00147014 · Cited by 29
Dinos, G. P., Michelinaki, M., & Kalpaxis, D. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1441 · Cited by 36
Macrolide resistance in Streptococci and Haemophilus influenzae
Bozdoğan, B., & Appelbaum, P. C. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.006 · Cited by 30
“Chittum and Champney [13] proposed that the hydroxyl group at position 6 of erythromycin interacts with lysine at position 63 of ribosomal protein L4 and inhibits fixation of this protein on 23S rRNA.”
BackgroundBowers, A. K., Keller, J. A., & Dutcher, S. K. (2003) · Genetics · doi:10.1093/genetics/164.4.1345 · Cited by 20
Nikolay, R., Schlömer, R., Schmidt, S., Mueller, S., Heubach, A., & Deuerling, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku381 · Cited by 21
“It is known since a long time that application of translation inhibitors such as chloramphenicol (40,41) and erythromycin (42,43) provoke assembly defects of the large ribosomal subunit in E.”
BackgroundInhibition of nuclear pre‐mRNA splicing by antibiotics in vitro
Hertweck, M., Hiller, R., & Mueller, M. W. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02636.x · Cited by 22
Wang, L., Liu, L., & Zhou, X. (2023) · Food and Bioprocess Technology · doi:10.1007/s11947-023-03256-1 · Cited by 15
“However, erythromycin or some macrolide antibiotics can not only prevent elongation of polypeptide chains but also inhibit the formation of large ribosomal subunits (Chittum & Champney, 1995).”
Gregory, S. T., Cate, J. H. D., & Dahĺberg, A. E. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.14.4382-4385.2001 · Cited by 14
The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus
Frazier, A. D., & Champney, W. S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks182 · Cited by 12
Self-citationEffects of macrolide antibiotics on ribosome function
Allen, N. E. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8105-0_16 · Cited by 14
“In E. coli, differential inhibition of subunit assembly could not be demonstrated with other MLS agents tested [ 120 ].”
BackgroundChampney, W. S., Mentens, N., & Zurawick, K. (2004) · Current Microbiology · doi:10.1007/s00284-004-4306-7 · Cited by 13
“pneumoniae [7], Staphylococcus aureus [9], Escherichia coli [11] and Haemophilus influenzae [10].”
Self-citationOuattara, M., Coulibaly, S., & N'Guessan, J.-P. D. U. (2020) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2020.103005 · Cited by 13
Inhibition of Ribosomal Subunit Synthesis in Escherichia coli by the Vanadyl Ribonucleoside Complex
Frazier, A. D., & Champney, W. S. (2013) · Current Microbiology · doi:10.1007/s00284-013-0350-5 · Cited by 8
“Cellular lysates were prepared by a lysozyme–freeze thaw method as previously described [13].”
BackgroundMethodSelf-citationLes macrolides : une diversité de mécanismes de résistance
Canu, A., & Leclercq, R. (2002) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(02)80005-1 · Cited by 8
Effects of Antibiotics on Microbial Communities Responsible for Perchlorate Degradation
Zheng, X., Jiang, B., Lang, H., Zhang, R., Li, Y., Bian, Y., & Guan, X. (2019) · Water Air & Soil Pollution · doi:10.1007/s11270-019-4302-y · Cited by 7
“S subunit (Spížek and Řezanka 2004; Chittum and Champney 1995).”
BackgroundBarbosa, M. A., Angelin, L. G., Saikawa, G. I. A., Oliveira, C. J. C. D., da Silva, S. S., Vendruscolo, J. W., Marinello, P. C., Fujita, T. C., Rocha, S. P. D., Watanabe, M. A. E., et al. (2015) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v44i1.34798 · Cited by 6
Fluorescence-based monitoring of ribosome assembly landscapes
Nikolay, R., Schlömer, R., Mueller, S., & Deuerling, E. (2015) · BMC Molecular Biology · doi:10.1186/s12867-015-0031-y · Cited by 6
“It has been shown that translation inhibitors such as chloramphenicol [16,17,40,41], erythromycin [16,17,42,43] and neomycin [18,44,45] cause directly or indirectly assembly”
BackgroundThree Methods to Assay Inhibitors of Ribosomal Subunit Assembly
Champney, W. S. (2007) · Methods in molecular medicine · doi:10.1007/978-1-59745-246-5_6 · Cited by 6
Self-citationMacrolides, Clindamycin, and Ketolides
Sivapalasingam, S., & Steigbigel, N. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00030-8 · Cited by 10
Ma, W., Liang, H., He, K., Li, T., Hui, Q., Zhang, Y., Dong, Y., Jia, Y., & Song, L. (2025) · Foods · doi:10.3390/foods14122011 · Cited by 5
“Erythromycin has been shown to inhibit the assembly of the 50 S subunit in E. coli via L22 [53].”
A promoted MALDI-TOF-MS platform towards rapid and accurate identifications of bacteria
Zhao, N., Wang, H., Li, J., Lin, X., Guo, L., & Guo, X. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.110356 · Cited by 5
Macromolecular Structure Assembly as a Novel Antibiotic Target
Champney, S. (2022) · Antibiotics · doi:10.3390/antibiotics11070937 · Cited by 3
“A 32S precursor to the mature 50S subunit accumulates in cells treated with 50S subunit-specific antimicrobials [35,36].”
BackgroundMačvanin, M., de Valdivia, E. I. G., Ardell, D. H., & Isaksson, L. A. (2007) · Journal of Bacteriology · doi:10.1128/jb.01004-07 · Cited by 3
“Macrolides are antibacterial agents whose primary mode of action is inhibition of protein synthesis (4, 20, 35).”
BackgroundKhmil, N. V. (2026) · Low Temperature Physics · doi:10.1063/10.0042169 · Cited by 1
Akinwale, O. A., Emokpae, U. O., Adebogun, O. M., Adeoye-Isijola, M. O., & Olajuyigbe, O. O. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.14.2.0033 · Cited by 2
“Since macrolides blocks protein synthesis by interacting with the ribosomal subunit [49] to inhibit translocation of peptidyl-tRNA from the receptor to the donor site and the initial steps of 50S subunit assembly [50], erythromycin and its different pro-drugs appear to be less potent inhibitors of drug metabolism [51].”
BackgroundOlajuyigbe, O. O., & Adekola, O. O. (2011) · Pharmacologia · doi:10.5567/pharmacologia.2012.221.226 · Cited by 1
Quantitative susceptibility testing of chlamydia trachomatis against clinically relevant drugs.
Matadin, R. (2017) · ResearchSpace (University of KwaZulu-Natal) · Cited by 1
Intracellular regulation in bacteria
Nilsson, K. (2006) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Fate and biological activity of antibiotics used in ethanol production.
Compart, D. M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Inhibitors of Initiation Phase of Bacterial Protein Synthesis
Marquez, V., Sohmen, D., & Wilson, D. N. (2009) · Wiley eBooks · doi:10.1002/9780470015902.a0021835
Usary, J. (2000) · Digital Commons - East Tennessee State University (East Tennessee State University)
Culver, G. M., & Rife, J. P. (2013) · Antibiotics · doi:10.1002/9783527659685.ch15
Siibak, T. (2005) · DSpace repository (University of Tartu)
An Investigation of Bacterial Ribonucleases as an Antibiotic Target
Frazier, A. D. (2012) · Digital Commons - East Tennessee State University (East Tennessee State University)
Nazemof, N. (2009) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2009-08825 · Cited by 1
Riviere, N. A., Jiang, L., Wu, X., Casabonne, M. C., Guo, L., Smith, L. Y., da Silva, W. M., Cataldi, A. A., Xing, K., Bei, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.18.629128
Rankine-Wilson, L., & Av‐Gay, Y. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00093
Riviere, N. A., Jiang, L., Wu, X., Farace, P., Guo, L., Smith, L. Y., Silva, W., Cataldi, A. A., Xing, K., Bei, J., et al. (2026) · Brazilian Journal of Microbiology · doi:10.1007/s42770-026-02048-x
“The proteins encoded by these genes predominantly bind to the 23 S rRNA and play essential roles during the early stages of 50 S subunit assembly [26], whereas RpsC binds to the 30 S subunit.”
Metadata
- Authors
- Chittum, H. S., & Champney, W. S.
- Affiliations
- East Tennessee State University (US)
- Venue
- Current Microbiology
- Published
- 1995-05
- Volume
- 30
- Issue
- 5
- Pages
- 273-279
- ISSN
- 0343-8651 (ISSN-L)
- 1432-0991
- OpenAlex
- W2070110265
- Cited by
- 88
- References
- 46
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- erythromycin, macrolide antibiotics, ribosome assembly, 50S ribosomal subunit, Escherichia coli, ribosomal protein L22, ribosomal protein L4, erythromycin resistance, ribosomal proteins
- MeSH terms
- Anti-Bacterial Agents, Drug Resistance, Microbial, Erythromycin, Escherichia coli, Mutation, Peptide Chain Elongation, Translational, Ribosomal Proteins, Ribosomes, Structure-Activity Relationship, Protein Biosynthesis, RNA-Binding Proteins, Azithromycin, Escherichia coli Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.